Adequate 0 8 0 8 O
anticoagulation 9 24 9 24 B-treatment
can 25 28 25 28 O
not 28 31 28 31 O
be 32 34 32 34 O
achieved 35 43 35 43 O
due 44 47 44 47 O
to 48 50 48 50 O
severe 51 57 51 57 B-chronic_disease
hemophilia 58 68 58 68 I-chronic_disease
, 68 69 68 69 O
severe 70 76 70 76 O
hemorrhage 77 87 77 87 B-chronic_disease
diathesis 88 97 88 97 I-chronic_disease
, 97 98 97 98 O
severe 99 105 99 105 O
gastrointestinal 106 122 106 122 B-chronic_disease
ulcers 123 129 123 129 I-chronic_disease
, 129 130 129 130 O
or 131 133 131 133 O
are 134 137 134 137 O
recipients 138 148 138 148 O
of 149 151 149 151 O
vitamin 152 159 152 159 B-treatment
K 160 161 160 161 I-treatment
antagonist 162 172 162 172 I-treatment
medications 173 184 173 184 I-treatment

Body 0 4 185 189 O
weight 5 11 190 196 B-clinical_variable
< 12 13 197 198 O
18 14 16 199 201 B-upper_bound
kg 17 19 202 204 I-upper_bound
( 20 21 205 206 I-upper_bound
39.7 21 25 206 210 I-upper_bound
lbs 26 29 211 214 I-upper_bound
) 29 30 214 215 I-upper_bound

Cardiac 0 7 216 223 B-chronic_disease
impairments 8 19 224 235 I-chronic_disease
such 20 24 236 240 O
as 25 27 241 243 O
uncontrolled 28 40 244 256 O
arrhyth¬mia 41 52 257 268 B-chronic_disease
, 52 53 268 269 O
unstable 54 62 270 278 B-chronic_disease
angina 63 69 279 285 I-chronic_disease
, 69 70 285 286 O
decompensated 71 84 287 300 B-chronic_disease
congestive 85 95 301 311 I-chronic_disease
heart 96 101 312 317 I-chronic_disease
failure 102 109 318 325 I-chronic_disease
, 109 110 325 326 O
or 111 113 327 329 O
valvular 114 122 330 338 B-chronic_disease
disease 123 130 339 346 I-chronic_disease

Currently 0 9 347 356 O
being 10 15 357 362 O
administered 16 28 363 375 O
ACE 29 32 376 379 B-treatment
inhibitors 33 43 380 390 I-treatment
that 44 48 391 395 O
can 49 52 396 399 O
not 52 55 399 402 O
be 56 58 403 405 O
withheld 59 67 406 414 O
for 68 71 415 418 O
at 72 74 419 421 O
least 75 80 422 427 O
24 81 83 428 430 B-lower_bound
hours 84 89 431 436 I-lower_bound
prior 90 95 437 442 I-lower_bound
to 96 98 443 445 O
each 99 103 446 450 O
apheresis 104 113 451 460 B-treatment
treatment 114 123 461 470 I-treatment
( 124 125 471 472 O
Note 125 129 472 476 O
: 129 130 476 477 O
The 131 134 478 481 O
time 135 139 482 486 O
period 140 146 487 493 O
to 147 149 494 496 O
withhold 150 158 497 505 O
ACE 159 162 506 509 O
inhibitors 163 173 510 520 O
should 174 180 521 527 O
be 181 183 528 530 O
prolonged 184 193 531 540 O
, 193 194 540 541 O
if 195 197 542 544 O
determined 198 208 545 555 O
by 209 211 556 558 O
the 212 215 559 562 O
treating 216 224 563 571 O
physician 225 234 572 581 O
, 234 235 581 582 O
considering 236 247 583 594 O
each 248 252 595 599 O
individual 253 263 600 610 O
's 263 265 610 612 O
renal 266 271 613 618 O
function 272 280 619 627 O
and 281 284 628 631 O
the 285 288 632 635 O
biological 289 299 636 646 O
half 300 304 647 651 O
- 304 305 651 652 O
life 305 309 652 656 O
of 310 312 657 659 O
the 313 316 660 663 O
ACE 317 320 664 667 B-treatment
- 320 321 667 668 I-treatment
inhibitor 321 330 668 677 I-treatment
currently 331 340 678 687 O
in 341 343 688 690 O
use 344 347 691 694 O
. 347 348 694 695 O
) 348 349 695 696 O

Currently 0 9 697 706 O
being 10 15 707 712 O
administered 16 28 713 725 O
antihypertensive 29 45 726 742 B-treatment
drugs 46 51 743 748 I-treatment
other 52 57 749 754 O
than 58 62 755 759 O
ACE 63 66 760 763 B-treatment
inhibitors 67 77 764 774 I-treatment
( 78 79 775 776 O
e.g. 79 83 776 780 O
, 83 84 780 781 O
Angiotensin 85 96 782 793 B-treatment
II 97 99 794 796 I-treatment
receptor 100 108 797 805 I-treatment
blockers 109 117 806 814 I-treatment
( 118 119 815 816 I-treatment
ARBs 119 123 816 820 I-treatment
) 123 124 820 821 I-treatment
that 125 129 822 826 O
can 130 133 827 830 O
not 133 136 830 833 O
be 137 139 834 836 O
withheld 140 148 837 845 O
on 149 151 846 848 O
the 152 155 849 852 O
day 156 159 853 856 O
of 160 162 857 859 O
apheresis 163 172 860 869 B-treatment
until 173 178 870 875 O
after 179 184 876 881 O
the 185 188 882 885 O
procedure 189 198 886 895 O

Extracorporeal 0 14 896 910 B-treatment
circulation 15 26 911 922 I-treatment
therapy 27 34 923 930 I-treatment
with 35 39 931 935 I-treatment
Liposorber 40 50 936 946 I-treatment
® 50 51 946 947 I-treatment
LA-15 52 57 948 953 I-treatment
System 58 64 954 960 I-treatment
can 65 68 961 964 O
not 68 71 964 967 O
be 72 74 968 970 O
tolerated 75 84 971 980 O
due 85 88 981 984 O
to 89 91 985 987 O
severe 92 98 988 994 O
cardiac 99 106 995 1002 B-chronic_disease
insufficiency 107 120 1003 1016 I-chronic_disease
, 120 121 1016 1017 O
acute 122 127 1018 1023 B-chronic_disease
myocardial 128 138 1024 1034 I-chronic_disease
infarction 139 149 1035 1045 I-chronic_disease
, 149 150 1045 1046 O
severe 151 157 1047 1053 O
cardiac 158 165 1054 1061 B-chronic_disease
arrhythmia 166 176 1062 1072 I-chronic_disease
, 176 177 1072 1073 O
acute 178 183 1074 1079 O
apoplexy 184 192 1080 1088 B-chronic_disease
, 192 193 1088 1089 O
severe 194 200 1090 1096 O
uncontrollable 201 215 1097 1111 B-chronic_disease
hypertension 216 228 1112 1124 I-chronic_disease
, 228 229 1124 1125 O
or 230 232 1126 1128 O
severe 233 239 1129 1135 O
uncontrollable 240 254 1136 1150 B-chronic_disease
hypotension 255 266 1151 1162 I-chronic_disease

Hypersensitivity 0 16 1163 1179 O
to 17 19 1180 1182 O
dextran 20 27 1183 1190 B-allergy_name
sulfate 28 35 1191 1198 I-allergy_name
, 35 36 1198 1199 O
heparin 37 44 1200 1207 B-allergy_name
, 44 45 1207 1208 O
or 46 48 1209 1211 O
ethylene 49 57 1212 1220 B-allergy_name
oxide 58 63 1221 1226 I-allergy_name

Medical 0 7 1227 1234 B-chronic_disease
condition 8 17 1235 1244 I-chronic_disease
or 18 20 1245 1247 O
disorder 21 29 1248 1256 O
that 30 34 1257 1261 O
would 35 40 1262 1267 O
limit 41 46 1268 1273 O
life 47 51 1274 1278 B-clinical_variable
expectancy 52 62 1279 1289 I-clinical_variable
to 63 65 1290 1292 O
less 66 70 1293 1297 O
than 71 75 1298 1302 O
the 76 79 1303 1306 O
primary 80 87 1307 1314 O
clinical 88 96 1315 1323 O
study 97 102 1324 1329 O
endpoint 103 111 1330 1338 O
or 112 114 1339 1341 O
that 115 119 1342 1346 O
may 120 123 1347 1350 O
cause 124 129 1351 1356 O
noncompliance 130 143 1357 1370 O
with 144 148 1371 1375 O
the 149 152 1376 1379 O
study 153 158 1380 1385 O
plan 159 163 1386 1390 O
or 164 166 1391 1393 O
confound 167 175 1394 1402 O
the 176 179 1403 1406 O
data 180 184 1407 1411 O
analysis 185 193 1412 1420 O

Only 0 4 1421 1425 O
patients 5 13 1426 1434 O
18 14 16 1435 1437 B-lower_bound
- 16 17 1437 1438 O
21 17 19 1438 1440 B-upper_bound
years 20 25 1441 1446 I-upper_bound
of 26 28 1447 1449 O
age 29 32 1450 1453 B-age
may 33 36 1454 1457 O
sign 37 41 1458 1462 O
the 42 45 1463 1466 O
informed 46 54 1467 1475 O
consent 55 62 1476 1483 O
on 63 65 1484 1486 O
their 66 71 1487 1492 O
own 72 75 1493 1496 O
behalf 76 82 1497 1503 O

Patient 0 7 1504 1511 O
is 8 10 1512 1514 O
greater 11 18 1515 1522 O
than 19 23 1523 1527 O
21 24 26 1528 1530 B-lower_bound
years 27 32 1531 1536 I-lower_bound
of 33 35 1537 1539 O
age 36 39 1540 1543 B-age

Pediatric 0 9 1544 1553 B-treatment
post 10 14 1554 1558 I-treatment
renal 15 20 1559 1564 I-treatment
transplant 21 31 1565 1575 I-treatment
patients 32 40 1576 1584 O
with 41 45 1585 1589 O
nephrotic 46 55 1590 1599 B-chronic_disease
syndrome 56 64 1600 1608 I-chronic_disease
associated 65 75 1609 1619 O
with 76 80 1620 1624 O
primary 81 88 1625 1632 B-chronic_disease
FSGS 89 93 1633 1637 I-chronic_disease

Pregnant 0 8 1638 1646 B-pregnancy

Refractory 0 10 1647 1657 B-chronic_disease
nephrotic 11 20 1658 1667 I-chronic_disease
syndrome 21 29 1668 1676 I-chronic_disease
in 30 32 1677 1679 O
which 33 38 1680 1685 O
standard 39 47 1686 1694 B-treatment
treatment 48 57 1695 1704 I-treatment
options 58 65 1705 1712 O
are 66 69 1713 1716 O
not 70 73 1717 1720 O
well 74 78 1721 1725 O
tolerated 79 88 1726 1735 O
( 89 90 1736 1737 O
i.e. 90 94 1737 1741 O
, 94 95 1741 1742 O
patients 96 104 1743 1751 O
intolerant 105 115 1752 1762 O
to 116 118 1763 1765 O
standard 119 127 1766 1774 B-treatment
therapies 128 137 1775 1784 I-treatment
due 138 141 1785 1788 O
to 142 144 1789 1791 O
severe 145 151 1792 1798 O
side 152 156 1799 1803 O
effects 157 164 1804 1811 O
that 165 169 1812 1816 O
negatively 170 180 1817 1827 O
affect 181 187 1828 1834 O
quality 188 195 1835 1842 O
of 196 198 1843 1845 O
life 199 203 1846 1850 O
without 204 211 1851 1858 O
providing 212 221 1859 1868 O
an 222 224 1869 1871 O
acceptable 225 235 1872 1882 O
level 236 241 1883 1888 O
of 242 244 1889 1891 O
clinical 245 253 1892 1900 O
benefit 254 261 1901 1908 O
) 261 262 1908 1909 O

Refractory 0 10 1910 1920 B-chronic_disease
nephrotic 11 20 1921 1930 I-chronic_disease
syndrome 21 29 1931 1939 I-chronic_disease
in 30 32 1940 1942 O
which 33 38 1943 1948 O
standard 39 47 1949 1957 B-treatment
treatment 48 57 1958 1967 I-treatment
options 58 65 1968 1975 O
are 66 69 1976 1979 O
unsuccessful 70 82 1980 1992 O
( 83 84 1993 1994 O
i.e. 84 88 1994 1998 O
, 88 89 1998 1999 O
patient 90 97 2000 2007 O
is 98 100 2008 2010 O
unresponsive 101 113 2011 2023 O
to 114 116 2024 2026 O
standard 117 125 2027 2035 B-treatment
corticosteroid 126 140 2036 2050 I-treatment
and/or 141 147 2051 2057 O
calcineurin 148 159 2058 2069 B-treatment
inhibitor 160 169 2070 2079 I-treatment
therapy 170 177 2080 2087 I-treatment
for 178 181 2088 2091 O
at 182 184 2092 2094 O
least 185 190 2095 2100 O
8 191 192 2101 2102 B-lower_bound
weeks 193 198 2103 2108 I-lower_bound
resulting 199 208 2109 2118 O
in 209 211 2119 2121 O
failure 212 219 2122 2129 O
to 220 222 2130 2132 O
achieve 223 230 2133 2140 O
complete 231 239 2141 2149 B-treatment
or 240 242 2150 2152 O
partial 243 250 2153 2160 B-treatment
remission 251 260 2161 2170 I-treatment
) 260 261 2170 2171 O

Refractory 0 10 2172 2182 O
or 11 13 2183 2185 O
recurrent 14 23 2186 2195 O
nephrotic 24 33 2196 2205 B-chronic_disease
syndrome 34 42 2206 2214 I-chronic_disease
in 43 45 2215 2217 O
which 46 51 2218 2223 O
standard 52 60 2224 2232 B-treatment
therapy 61 68 2233 2240 I-treatment
is 69 71 2241 2243 O
contraindicated 72 87 2244 2259 O

Simultaneously 0 14 2260 2274 O
participating 15 28 2275 2288 O
in 29 31 2289 2291 O
another 32 39 2292 2299 O
investigational 40 55 2300 2315 B-treatment
drug 56 60 2316 2320 I-treatment
or 61 63 2321 2323 O
device 64 70 2324 2330 B-treatment
study 71 76 2331 2336 I-treatment

The 0 3 2337 2340 O
safety 4 10 2341 2347 O
of 11 13 2348 2350 O
the 14 17 2351 2354 O
use 18 21 2355 2358 O
of 22 24 2359 2361 O
Liposorber 25 35 2362 2372 B-treatment
® 35 36 2372 2373 I-treatment
in 37 39 2374 2376 O
pregnant 40 48 2377 2385 B-pregnancy
women 49 54 2386 2391 B-gender
has 55 58 2392 2395 O
not 59 62 2396 2399 O
been 63 67 2400 2404 O
studied 68 75 2405 2412 O
. 75 76 2412 2413 O
There 77 82 2414 2419 O
may 83 86 2420 2423 O
be 87 89 2424 2426 O
unknown 90 97 2427 2434 O
risks 98 103 2435 2440 O
to 104 106 2441 2443 O
an 107 109 2444 2446 O
embryo 110 116 2447 2453 O
/ 116 117 2453 2454 O
fetus 117 122 2454 2459 O
. 122 123 2459 2460 O
Sexually 124 132 2461 2469 O
active 133 139 2470 2476 O
women 140 145 2477 2482 O
of 146 148 2483 2485 O
child 149 154 2486 2491 O
bearing 155 162 2492 2499 O
potential 163 172 2500 2509 O
should 173 179 2510 2516 O
avoid 180 185 2517 2522 O
pregnancy 186 195 2523 2532 B-pregnancy
during 196 202 2533 2539 O
the 203 206 2540 2543 O
use 207 210 2544 2547 O
of 211 213 2548 2550 O
the 214 217 2551 2554 O
Liposorber 218 228 2555 2565 B-treatment
device 229 235 2566 2572 I-treatment
and 236 239 2573 2576 O
throughout 240 250 2577 2587 O
the 251 254 2588 2591 O
study 255 260 2592 2597 O
duration 261 269 2598 2606 O
. 269 270 2606 2607 O
) 270 271 2607 2608 O

Thyroid 0 7 2609 2616 B-chronic_disease
disease 8 15 2617 2624 I-chronic_disease
or 16 18 2625 2627 O
liver 19 24 2628 2633 B-chronic_disease
abnormalities 25 38 2634 2647 I-chronic_disease

Unresolved 0 10 2648 2658 O
systemic 11 19 2659 2667 B-chronic_disease
or 20 22 2668 2670 I-chronic_disease
local 23 28 2671 2676 I-chronic_disease
infection 29 38 2677 2686 I-chronic_disease
that 39 43 2687 2691 O
could 44 49 2692 2697 O
affect 50 56 2698 2704 O
the 57 60 2705 2708 O
clinical 61 69 2709 2717 B-treatment
study 70 75 2718 2723 I-treatment
outcomes 76 84 2724 2732 O

planning 0 8 2733 2741 B-pregnancy
to 9 11 2742 2744 I-pregnancy
become 12 18 2745 2751 I-pregnancy
pregnant 19 27 2752 2760 I-pregnancy
prior 28 33 2761 2766 O
to 34 36 2767 2769 O
completing 37 47 2770 2780 O
the 48 51 2781 2784 O
study 52 57 2785 2790 O

